Minesapride - Sumitomo Pharma
Alternative Names: DSP-6952Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Pharma
- Class Benzamides; Gastrokinetics; Irritable bowel syndrome therapies; Morpholines; Piperidines; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Constipation; Irritable bowel syndrome